Vimarsana
Biggest News Aggregation in the World

Page 3 - Shared Decision Making News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shared Decision Making. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shared Decision Making Today - Breaking & Trending Today

Person-centred health care means ensuring that affected communities are leaders and partners in research - Vimarsana News

Person-centred health care means ensuring that affected communities are leaders and partners in research

Research partnerships with the people and communities affected help to challenge health inequities, and support person-centred care in health systems.

Desmoid Tumors: Impact and Quality of Life - Vimarsana News

Desmoid Tumors: Impact and Quality of Life

Explore the multifaceted impact of desmoid tumors on patients’ physical, functional, and psychosocial well-being as experts emphasize effective symptom management and quality-of-life enhancements.

Source: ajmc.com
Managing Desmoid Tumor Challenges - Vimarsana News

Managing Desmoid Tumor Challenges

Explore effective approaches in handling fatigue, insomnia, and financial difficulties of patients with desmoid tumors as experts highlight psychosocial support and treatment considerations for quality care.

Source: ajmc.com
Patient Toxicity and QOL Concerns Must Be Considered in Breast Cancer Treatment Decision-Making - Vimarsana News

Patient Toxicity and QOL Concerns Must Be Considered in Breast Cancer Treatment Decision-Making

Jane L. Meisel, MD, discusses the importance of prioritizing patients’ toxicity concerns and quality of life in the management of breast cancer.

Third Line Treatment in Chronic GVHD - Vimarsana News

Third Line Treatment in Chronic GVHD

Drs Yi-Bin Chen, Corey Cutler, Hannah Choe, and Mitchell Horwitz discuss a complex chronic GVHD case post-allogeneic transplant. The panel explores third-line options, including belumosudil, ibrutinib, photopheresis, and clinical trials, emphasizing shared decision-making and the need for well-designed trials in guiding treatment decisions.